Revolutionary Thalassemia Drug Added to Cypriot Health System
Cypriot thalassemia patients can now receive a groundbreaking new medication through the national health system, despite the high costs. One in seven Cypriots is a carrier of thalassemia, and Cyprus has the highest rate of patients relative to population worldwide. The new drug marks a turning point in treatment.